Oura is valued at approximately $11 billion following a major funding round in 2025. Headquartered in Oulu, Finland, with significant operations in San Francisco, California, United States, Oura develops the Oura Ring, a wearable health-tracking device that measures sleep, activity, heart rate and other biometrics to deliver personalized health insights.
The company’s platform blends advanced sensors with subscription software and has grown substantially in sales and revenue as wearable health tech adoption increases.
What Is Oura and What Does It Do?
Founded in 2013, Oura designs and manufactures the Oura Ring, a smart wearable worn on the finger that tracks health and wellness metrics including sleep stages, body temperature, heart rate variability, and activity levels. The data feeds into a companion app that provides personalized insights and trends.
Oura’s product combines hardware and subscription-based analytics to support proactive health, recovery, and lifestyle improvement, making it popular with consumers, athletes, and health-focused professionals in multiple global markets.
How Much Funding Has Oura Raised?
1. Series C Round
- Amount Raised: ~$100 million
- Date: 2021
- Lead Investors: The Chernin Group, Elysian Park, Temasek, JAZZ Venture Partners, Eisai
- Purpose: Expand technology, R&D, and global growth
- Valuation: ~$800 million (approx., pre-Series D growth)
2. Series D Round
- Amount Raised: $200 million
- Date: December 2024
- Lead Investors: Fidelity Management & Research Company, with participation from Dexcom (plus $75 million strategic from Dexcom)
- Purpose: Expand product offerings, science partnerships, and growth infrastructure
- Valuation: ~$5.2 billion
3. Series E Round
- Amount Raised: ~$875 million–$900 million
- Date: October 2025
- Lead Investors: Fidelity Management & Research Company, ICONIQ Capital, Whale Rock Capital Management, Atreides Management (reported)
- Purpose: Scale manufacturing and global expansion, invest in AI-driven features and product innovation
- Valuation: Around $11 billion
Total Funding Raised: Approximately $1.2 billion+ across structured rounds
Latest Funding Date: October 2025
Latest Known Valuation: Approximately $11 billion
Key Investors
- Fidelity Management & Research Company
- Global investment manager that led Oura’s Series D and Series E funding.
- ICONIQ Capital
- Private investment firm participating in the 2025 Series E raise.
- Whale Rock Capital Management
- Growth equity investor in the 2025 Series E round.
- Atreides Management
- Strategic investor in late-stage funding.
- Dexcom
- Medical device partner who backed Oura’s Series D round, strengthening health integrations.
- Temasek, The Chernin Group, Elysian Park Ventures, JAZZ Venture Partners, Eisai
- Early and growth investors supporting Series C and earlier strategy.
Where Is Oura’s Headquarters?
Oura’s corporate headquarters is in Oulu, Finland, with major operational presence in San Francisco, California, United States to support business development, engineering, and global growth.
What’s Next for Oura?
Oura plans to use its latest capital to expand production capacity, enhance AI-powered health insights, broaden global distribution channels, and build deeper partnerships that integrate wearable data with health and wellness services. The company may also explore future public listing options as it continues scaling internationally.
Get Investor and Funding Insights with TexAu
TexAu provides verified investor and funding data for companies like Oura. Explore insights on wearable tech, health monitoring innovation, and high-growth funded startups shaping the future of personal health technologies.
Sign up for Free to access real time investor and funding intelligence.